Joint Implants will always be needed
January 5, 2009
Medical devices not immune to recession worries | www.boston.com
This article highlights some of the concerns regarding the economy and utilization of surgical implants. While patients may defer total hip and knee surgery, they will ultimately undergo surgery for pain relief and restoration of function. The number of baby boomers with arthritis will increase the surgical volume. Insurance continues to cover the cost of surgery for the majority of patients.
There is a need for a total joint registry in the United States
August 6, 2008
New York Times July 29, 2008 A call for warning system on artificial joints | www.nytimes.com
The AAOS has established the need for a total joint registry however there are financial and legal hurdles that must be overcome. The value of total joint registries have been realized in Europe and Australia with a significant reduction in the revision rate of implants. A joint registry can provide an early warning system on issues or problems related to a particular implant design or surgical technique. With the rising cost of healthcare, a registry in the United States can be a cost effective use of our limited healthcare resources. If the data can be delivered to the orthopedic community in a timely and understandable fashion, it should and will influence the surgeon's behavior and decision making such that patients and society are benefited.
July 2, 2007
Mail order drugs flying off shelves | www.gazette.com
I could not agree more that people should have a choice and maybe the pricing markey is the US will finally drop after how it see it will work all pharmacies across the country. The manufacturers need to be held responsible for this issue, they caused it with raising prices and making more of a profit. They should join in with the oil industry these two make a good pair on how to rep off the consumer.
Page : 11 to 3 of 3
February 7, 2012
What do the cloud, collaboration and virtualization have in common?
January 27, 2012
Clinical diagnostic acquisitions dominate 2011 top ten list
January 12, 2012
Gene therapy success threatens drugs for hemophilia and rare diseases
December 13, 2011
Medtech M&A activity accelerates in 2011
November 30, 2011